missing translation for 'onlineSavingsMsg'
Learn More
Learn More
-Immunocytochemistry-Immunofluorescence-NB100-105-img0023.jpg-650.jpg)
-Western-Blot-NB100-105-img0022.jpg-650.jpg)
-Western-Blot-NB100-105-img0026.jpg-650.jpg)
HIF-1 alpha Antibody (H1alpha67), Novus Biologicals™
Mouse Monoclonal Antibody has been used in 891 publication
Marque: Novus Biologicals NB100-105
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
HIF-1 alpha Monoclonal specifically detects HIF-1 alpha in Human, Mouse, Rat, Porcine, Bovine, Canine, Feline, Ferret, Monkey, Primate, Rabbit, Sheep, Xenopus samples. It is validated for Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Immunoassay, Immunoblotting, In vitro assay, Gel Super Shift Assays, Proximity Ligation Assay, Tissue Culture Substratum, Ligand Activation, Immunohistochemistry Free-Floating, Knockout Validated, Knockdown Validated.
Spécification
| HIF-1 alpha | |
| Monoclonal | |
| 1.0 mg/mL | |
| Western Blot 1:500, Simple Western, Chromatin Immunoprecipitation 1 - 5 ug/IP. Use reported in scientific literature, Flow Cytometry 1:10 - 1:1000, ELISA 1:100 - 1:2000. Use reported in scientific literature (PMID 20042684), Immunohistochemistry 1:20-1:50, Immunocytochemistry/Immunofluorescence 1:50, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Paraffin 1:20-1:50, Immunohistochemistry-Frozen 1:20-1:50, Immunoassay reported in scientific literature (PMID 26147748), Immunoblotting reported in multiple pieces of scientific literature, In vitro assay reported in multiple pieces of scientific literature, Gel Super Shift Assays 1:1 - 1:100. Use reported in scientific literature (PMID 22411794), Proximity Ligation Assay reported in scientific literature (PMID 27595394), Tissue Culture Substratum, Ligand Activation reported in scientific literature (PMID 26147748), Immunohistochemistry Free-Floating reported in scientific literature (PMID 33242463), Chromatin Immunoprecipitation (ChIP) 1-5 ug/IP, Knockout Validated reported in scientific literature (PMID 26861754), KnockDown Validated reported in scientific literature (PMID 32772041) | |
| AINT, anti-HIF-1 alpha, anti-HIF1A, ARNT interacting protein, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, BHLHE78, Class E basic helix-loop-helix protein 78, H1alpha67, HIF1, HIF-1 alpha, HIF1A, HIF-1A, HIF-1alpha, HIF-1-alpha, HIF1 | |
| Mouse | |
| 93 kDa | |
| 0.1 mL | |
| Adaptive Immunity, Angiogenesis, Autophagy, Cancer, Cardiovascular Biology, Cellular Markers, Chromatin Research, Cytokine Research, Hypoxia, Hypoxia Inducible Factors (HIF), Hypoxia Signaling, Immunology, Inflammation, Innate Immunity, Lipid and Metabolism, mTOR Pathway, Signal Transduction, Transcription Factors and Regulators | |
| 3091 | |
| Human, Mouse, Rat, Pig, Bovine, Canine, Feline, Ferret, Monkey, Primate, Rabbit, Sheep, Xenopus species | |
| Purified |
| Western Blot, ChIP Assay, Flow Cytometry, ELISA, Immunohistochemistry, Immunoblot, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry (Free Floating), Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Immunoprecipitation, In situ PLA, In vitro Assay, KnockDown | |
| H1alpha67 | |
| Unconjugated | |
| Q16665 | |
| HIF1A | |
| This HIF-1 alpha Antibody (H1alpha67) was developed against a fusion protein containing amino acids 432 - 528 of human HIF-1 alpha [Uniprot# Q16665]. | |
| Protein G purified | |
| RUO | |
| Primary | |
| Reactivity with Candida albicans reported by a customer review. Reactivity with Xenopus reported in the scientific literature (PMID: 18303027). | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG2b |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
For Research Use Only
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu